Kymera Therapeutics

Kymera Therapeutics Announces Discovery Collaboration with GSK to Advance New Treatment Modality

Collaboration to Accelerate the Discovery of Protein Degrading Therapeutics Cambridge, Mass. (April 4, 2018) – Kymera Therapeutics LLC, a biotechnology company pioneering targeted protein degradation as a transformative new approach to creating breakthrough medicines for patients, today announced